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OBJECTIVES: To characterize the natural history of 39 achondroplastic patients diagnosed by clinical, radiological
and molecular assessments.
METHODS: Observational and retrospective study of 39 patients who were attended at a public tertiary level
hospital between 1995 and 2016.
RESULTS: Diagnosis was made prenatally in 11 patients, at birth in 9 patients and within the first year of life in
13 patients. The most prevalent clinical findings were short stature, high forehead, trident hands, genu varum
and macrocephaly. The most prevalent radiographic findings were rhizomelic shortening of the long bones and
narrowing of the interpediculate distance of the caudal spine. There was motor developmental delay in 18 patients
and speech delay in 16 patients. The most common clinical intercurrences were middle ear dysfunction, sleep apnea,
limb pain and obesity from 2 to 9 years of age. One patient was large for the gestational age but did not develop
obesity. One patient developed hydrocephalus at 10 years old. The current age of the patients varies from 15months
to 36 years. The molecular study performed by Sanger sequencing of the common heterozygous mutation 1138G4A
in FGFR3 was positive in all patients. Four cases were inherited, and 35 were sporadic (paternal age from 19 to
66 years).
CONCLUSIONS: The diagnoses were made early based on clinical and radiographic findings. All cases were
confirmed molecularly. Despite presenting a benign course, it is necessary to establish a systematic protocol for
the surveillance of these patients due to the common clinical intercurrences.
KEYWORDS: Achondroplasia; Natural History; Growth; FGFR3.
’ INTRODUCTION
Achondroplasia (OMIM #10800) is the most common
non-lethal chondrodysplasia with an estimated incidence of
2.6:100,000. It is caused by missense mutations in FGFR3
(fibroblast growth factor receptor 3), with an autosomal
dominant pattern of inheritance and complete penetrance.
Most cases are de novo. In general, diagnosis is possible through
clinical and radiological findings recognizable at birth. Clinical
findings include disproportionately short stature, characteristic
faces with frontal bossing and midfacial retrusion, brachydac-
tyly, a trident appearance of the hands, lumbar hyperlordosis,
genu varum and joint hypermobility. The main radiological
findings are rhizomelic shortening of the long bones and
narrowing of the interpediculate distance of the caudal spine.
In cases in which there is doubt concerning the clinical
diagnosis, molecular testing is advised. Most patients
have good health with a benign course of the condition,
and there is no consensus regarding a clinical protocol for
follow-up. The main medical intercurrences related to the
disease are delayed motor milestones, obesity, hydro-
cephalus, craniocervical junction compression, obstructive
sleep apnea, otorhinolaryngologic diseases, spinal stenosis,
deformity of limbs, difficulty of socialization and depression.
The objective of this work is to characterize the natural
history of 39 achondroplastic patients diagnosed by clinical,
radiological, and molecular investigations.
’ MATERIALS AND METHODS
We performed an observational and retrospective study
of 43 patients with molecularly confirmed diagnoses of
achondroplasia from 1995 to 2016. Four patients were
excluded from the study due to being lost to follow-up.
An additional 3 patients had clinical and radiological
evidence, but are not included in this study due to the lack
of molecular studies. The included patients are attended
at the skeletal dysplasia medical ambulatory clinic, which
provides regular follow-up for a total of 150 patients with
different forms of nanism.DOI: 10.6061/clinics/2018/e324
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The study was approved by the research ethics commis-
sion for the analysis of research projects (CAPPesq) of the
Hospital das Clinicas Medical School of the University of São
Paulo (HC-FMUSP).
Clinical follow-up was performed annually when pos-
sible and consisted of the assessment of prenatal and birth
information obtained from records; physical examination of
height, weight, head circumference measurements, and neuro-
logic and dysmorphic evaluations; the assessment of devel-
opmental milestones; and a review of the family history.
Radiologic studies consisted of complete body X-rays of all
patients.
The molecular study consisted of Sanger sequencing of
exon 9 of FGFR3. (NM_000142)
’ RESULTS
Etiology
In our patients, sporadic cases were the majority – 36 out
of 40 (90%). Four patients were familial cases, with two affected
mothers and one affected father. The maternal age varied
from 19 to 39 years (mean 30.6 years and median 31 years).
The paternal age at conception of the sporadic cases varied
from 19 to 66 years (mean 37.2 years and median 34 years).
Diagnosis
The diagnosis was made in the prenatal period by ultra-
sound with findings of shortening of the long bones in 16/39
(41%) patients. In nine (23%) patients, the diagnosis was
made at birth, and in 13 (33%) patients, the diagnosis was
made within the first year. The latest diagnosis was made at
4 years old. The current age of our 39 patients varies from
15 months to 36 years (mean of 10.2 years and median of
6.5 years).
Neonatal Findings
Cesarean section was performed in 29/39 (74.3%) patients.
Thirty-four patients were born at term, 4/39 (10.2%) were
premature and 1/39 (2.6%) was born post-term.
Birth weight varied from 2170 g to 4700 g (mean 3165 g
and median 3235 g). Low birth weight (o2500 g) was present
in 4/39 (10.2%) patients, three who were premature and one
whose mother had hypertensive disease during pregnancy.
Birth length varied from 42 cm to 53 cm (mean 46 cm and
median 45.7 cm). Birth head circumference varied from
33 cm to 45 cm (mean 36.6 cm and median 36.5 cm).
Perinatal intercurrence occurred in 9/39 (23%) patients.
Three patients were premature, presenting respiratory
distress, pathological jaundice and deglutition disturbance.
One patient required three months of hospitalization. Other
common findings were perinatal asphyxia and sepsis.
Clinical Findings
The main clinical findings were: dwarfism in 39/39 (100%)
patients, frontal bossing in 38/39 (97%) patients, trident hands
in 38/39 (97%) patients, genu varum in 38/39 (97%) patients,
macrocephaly in 33/39 (84.6%) patients, thoracolumbar kyphosis
in 27/39 (69%) patients and joint hypermobility in 13/39 (33%)
patients (Figure 1).
Clinical Intercurrence
The most common intercurrences were middle ear dys-
function, sleep apnea, obesity and orthopedic abnormalities
(pain and excessive bowing of the lower limbs).
Recurrent infection of the middle ear occurred in 13/35
(37%) patients, persistent middle ear fluid in 3/35 (9%),
hearing loss in 4/35 (11%), and ventilation tube insertion was
performed for 4/35 (11%) patients.
Sleep disturbance was reported in 21/39 (53.8%) of patients
from the first month to 10 years of life (mean 3.94 years and
median 3 years old). Polysomnography was performed in
11 patients, and all showed sleep apnea. Adenotonsillectomy
was performed in 5 patients, and one patient underwent the
procedure twice.
Obesity was observed in 4/39 (10%) patients and occurred
from 2 years to 9 years (mean and median of 6 years).
One patient at 20 years old weighed 148 kg with a height of
139.5 cm (BMI 76.1 kg/m2); this patient also suffered from
depression, excessive snoring, sleep apnea and dyspnea at
rest and was referred for multidisciplinary care.
Pain in lower limbs occurred in 10/39 (25.6%) patients,
and excessive bowing of limbs in 4/39 (10.3%).
Figure 1 - Clinical findings in two achondroplastic patients. a-c) The clinical findings in a 6-year-old female patient. a) Anterior view of
the patient shows rhizomelic short-limb dwarfism and macrocephaly; b) the profile view demonstrates the common prominent kyphosis
and lumbar lordosis; c) the typical hand in this patient shows brachydactyly with a trident configuration; d) the profile picture
demonstrates the common phenotypic changes in achondroplasia: frontal bossing, midface hypoplasia and low nasal bridge; e) a 20-year-
old male patient whose weight is 148 kg and whose height is 139.5 cm.
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In terms of developmental milestones, head control was
achieved from 2 to 12 months of age (mean and median
of 6 months), sitting independently was achieved from 5 to
20 months (mean 9.3 months and median 8 months), and
walking independently was achieved from 7 to 50 months
(mean 18.6 months and median 17 months). Language devel-
opmental delay was observed in 16/39 (41%) patients.
All patients attend regular school with good performance.
One patient developed hydrocephalus at 10 years old.
Other complications related to the constriction of the cranio-
cervical junction and spinal cord stenosis were not reported.
One patient developed unrelated epilepsy.
One patient developed bilateral Wilms’ tumor at three
years old, for which chemotherapy and unilateral nephrectomy
were performed.
Radiological findings
The most common radiological findings were rhizomelic
shortening of the long bones in 39/39 (100%) patients; nar-
rowing of the interpediculate distance of the caudal spine in
34/39 (87%) patients; rounded ilia and horizontal acetabula
in 32/39 (82%) patients; mild, generalized metaphyseal changes
in 30/39 (73%) patients; proximal femoral radiolucency in
27/39 (70%) patients; and narrow sacrosciatic notch in 24/39
(62%) patients. These findings are compiled in Figure 2.
Cranial CT scans were done in 15/16 (94% patients (mean
3.4 years and median 1 year of age), and all patients except
one presented reduced foramen magnum size.
Molecular study
The molecular study consisted of Sanger sequencing of
exon 9 of FGFR3 (NM_000142). The common heterozygous
mutation 1138G4A was detected in all patients.
’ DISCUSSION
Diagnosis
Achondroplasia is a condition that is easily recognizable
in clinical and radiological findings. Early recognition of the
syndrome is important because it supports health providers’
decisions concerning type of labor, peripartum care, and
prognosis, as well as decreasing familial anxiety.
Ultrasonographic changes compatible with achondroplasia
are observable by 20 weeks of gestation and include the
rhizomelic shortening of limbs, a large head with frontal
bossing, midfacial retrusion and depressed nasal bridge,
and a trident configuration of the hands. The thoraco-
abdominal ratio is invariably 40.7, which is important
information at evaluation because of the other differential
diagnoses, including thanatophoric dysplasia, in which this
ratio is frequentlyo0.7, indicating a poor postnatal prognosis
due to a very narrow thorax and respiratory difficulties.
In our study, the diagnosis was made at an early stage.
By the first year of life, a total of 33 (89%) already had clinical
diagnoses.
Clinical findings
The most prevalent clinical findings were small statures
with rhizomelic shortening of limbs, large heads with frontal
bossing, midfacial retrusion and depressed nasal bridges,
trident configuration of the hands, and genu varum. These
findings are almost invariable in this condition and were also
present in our patients.
Neonatal intercurrences are not expected in patients with
achondroplasia unless other risk factors not related to the
disease are present, such as prematurity or hypertensive dis-
order of pregnancy. It is important to note that achondro-
plasic mothers must undergo caesarian section due to the
small size of the pelvis.
At birth, the weight of the patients was normal, length was
somewhat compromised, and the head circumference was
larger.
Anthropometric measures at birth of our patients were in
accordance with those expected for the disease, except for
one patient who was born large for the gestational age (40 w
and 4700 g). This finding is not related to the disease and was
probably due to maternal causes.
In general, by six months of age, the length was below -2
standard deviations (SD), and the head circumference was
above +1SD. It is noteworthy that there are specific growth
Figure 2 - Radiological findings of achondroplasia. a-d) X-ray studies of a 5-year-old patient. a) Anterior view of the vertebral column
shows narrowing of the interpediculate distance of the caudal spine; b) the typical hand presents brachydactyly with a trident
configuration; c) the pelvis has rounded ilia and horizonal acetabula, and the femurs are short with proximal radiolucency; d) the short
humerus also demonstrates rhizomelic dwarfism.
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charts (1) for achondroplasic patients and recommendations
for regular anthropometric evaluation (2).
Medical complications
The most prevalent clinical intercurrences of patients with
achondroplasia are middle ear dysfunction, sleep apnea,
obesity, craniocervical junction constriction, spinal stenosis,
hydrocephalus, limb deformity and pain, kyphosis, diffi-
culty in socialization and depression (2,3).
Short eustachian tubes may lead to recurrent infections of
the middle ear with persistent middle ear fluid; therefore,
ventilation tube insertion may be indicated (4) to prevent
hearing loss. The cause of upper airway obstruction in acho-
ndroplasia is multifactorial. There are anatomic causes that
lead to obstruction predisposing the patient to sleep apnea,
which can also be aggravated by adenoid hypertrophy. Patients
who undergo adenotonsillectomy are at risk of respiratory
intercurrences in post-operatory care and require careful
monitoring in the intensive care unit (4). Obesity may be
difficult to manage due to the short stature of the patients,
and it also aggravates other health problems such as sleep
apnea, spine and articulation pain, and deformity of limbs.
It is recommended that patients are stimulated by the
medical team and the family to consume a balanced diet
and to practice exercise. Despite these recommendations, it
is important to inform the families that the patients must
avoid some activities, due to the risk of injury to the spinal
at the craniocervical junction, such as collision sports, tram-
poline use, diving from boards, vaulting in gymnastics, and
hanging upside down from knees or feet on the playground.
Most patients are referred for orthopedic care and for
surgical evaluation due to the common findings of limb pain,
and limb deformity.
These findings were also prevalent in our patients. Sleep
apnea was present in 21/39 (54%) patients, middle ear
dysfunction in 19/35 (54%) patients, limb pain in 10/39
(26%) patients, and obesity in 4/39 (10%) patients. In our
cases, obesity occurred in four patients, with early onset
(from 2y to 9y). One patient had morbid obesity (148 kg and
139 cm) with severe respiratory complications and was
referred for multidisciplinary care with a good response.
Approximately 3-7% of patients with achondroplasia die
of sudden death in the first year of life due to the com-
pression of the brainstem or obstructive sleep apnea (5).
All our patients are alive.
Two patients developed unexpected intercurrences: one
patient developed epilepsy, and the other presented at 5 years
of age with bilateral Wilms’ tumor and underwent a partial
nephrectomy of one kidney and the total nephrectomy of
the other.
Developmental milestones
Motor development is constantly delayed in achondro-
plasic patients due to the large head size compared to the
small body and the transient hypotonia (6,7). There are
specific motor development charts for patients with achon-
droplasia (8), which state that head control is expected to be
achieved at 3-9 months of age, sitting independently to be
achieved at 7 to 14 months of age, and walking indepen-
dently to be achieved at 15 to 30 months of age.
In our study, 18 (46%) patients presented with motor
developmental delay.
The first words in patients with achondroplasia are
expected to be spoken at 7 to 17 months (8). Speech delay,
when present, is not related to the disease and is probably
due to the lack of external stimulation we hypothesize in
our patients. Intellectual impairment does not occur in the
disease, and patients can live productively.
In contrast to the results in the literature, our study
showed 16 (41%) patients with speech delay. All patients
attend regular school with good performance.
Image findings
X-ray findings are rhizomelic shortening of long bones,
which also become robust and tubular bones, a narrowing of
the interpediculate distance of the caudal spine, rounded
ilia and horizontal acetabula, a narrow sacrosciatic notch,
proximal femoral radiolucency, and mild, generalized meta-
physeal changes (9). Virtually all patients with achondroplasia
have reduced foramen magnum size as determined by
cranial CT examination. Reduced foramen magnum size
might cause compression of the brainstem at the cranio-
cervical junction and therefore results in elevated frequency
of hypotonia, tetraparesia, motor developmental delay,
central apnea, and sudden death (5).
The most prevalent radiographic findings of our patients
were in accordance with those in the literature; we found
rhizomelic shortening of long bones in 39 (100%) patients
and narrowing of the interpediculate distance of the caudal
spine in 34 (87%) patients.
Molecular study
Achondroplasia is a monogenic disorder caused by two
specific mutations in FGFR3 that are responsible for more
than 99% of the cases: 1138G4A in approximately 97%
and 1138G4C in approximately 2% of the cases (10). Both
mutations result in the substitution Gli380Arg. The p.Gly380Arg
mutation causes a constitutive activation of FGFR3, which is
a negative regulator of bone growth (11). These changes
result in excess inhibitory signaling in growth plate chon-
drocytes (12,13).
Achondroplasia cases are due to de novo mutations in 80%
of cases. De novomutations in guanine at the 1138 position of
FGFR3 occur mostly in the paternal germline and increase in
frequency with high paternal age (above 35 years) (14,15,16).
All our patients presented the classical mutation 1138G4A
in heterozygosity in FGFR3. Among 39 patients, 35 were
de novo sporadic cases and four were familial. Paternal age
varied in sporadic cases from 19 to 66 years (mean 38 and
median 34 years) and 15/35 (43%) of these fathers were
above 35 years old at conception.
Mutations in FGFR3 cause other disorders such as hypo-
chondroplasia, thanatophoric dysplasia and SADDAN (severe
achondroplasia with developmental delay and acanthosis
nigricans). In hypochondroplasia, the skeletal features are
similar but milder than those seen in achondroplasia.
Medical complications (spinal stenosis, tibial bowing,
obstructive apnea) occur less frequently, but intellectual
disability and epilepsy are more prevalent. Thanatophoric
dysplasia (TD) is a lethal dwarfism syndrome that presents
with cloverleaf skull, short ribs, narrow thorax, brachydac-
tyly, and evident skin folds along the limbs due to severe
micromelia. SADDAN has a similar phenotype to TD, with
the hallmark of acanthosis nigricans.
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In summary, achondroplasia is usually considered a benign
disorder, and medical complications are often neglected.
There are not yet well-established protocols for surveillance.
Most of existing protocols are made based on the medical
center’s experience or based on the patients’ individual
needs (17).
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